ArticleBMJ open ophthalmology2026

First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report.

Amr Saad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.